What have you always wondered about the economy? Tell Us

New effort ranks drugmakers by impact

Dan Gorenstein Jan 23, 2015
HTML EMBED:
COPY

New effort ranks drugmakers by impact

Dan Gorenstein Jan 23, 2015
HTML EMBED:
COPY

Pharmaceutical companies have one very obvious reason to avoid developing drugs and vaccines for infectious diseases like malaria and tuberculosis: There’s basically no money in it.

That’s because most people with those conditions are poor and have little means to pay. So what kind of incentive do you need to get drugmakers to take on global health epidemics? The answer may be a new index that ranks companies by who has the most effective drugs.

Click the media player above to hear more.

Marketplace is on a mission.

We believe Main Street matters as much as Wall Street, economic news is made relevant and real through human stories, and a touch of humor helps enliven topics you might typically find…well, dull.

Through the signature style that only Marketplace can deliver, we’re on a mission to raise the economic intelligence of the country—but we don’t do it alone. We count on listeners and readers like you to keep this public service free and accessible to all. Will you become a partner in our mission today?

Your donation is critical to the future of public service journalism. Support our work today – for as little as $5 – and help us keep making people smarter.